Indaptus Therapeutics Receives Notice of Allowance for Strategic Patent
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Indaptus Therapeutics (INDP) Adds to Yesterday's Gain, Up 25% Pre-Open
September 16, 2021 8:52 AM EDTIndaptus Therapeutics (NASDAQ: INDP) Adds to Yesterday's Gain, Up 25% Pre-Open
Climbed 52% yesterday... More